Mark Eisner - 14 Feb 2022 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role: Chief Medical Officer
Signature: /s/ Dorothy Pacini, Attorney-in-fact
Issuer symbol: FGEN
Transactions as of: 14 Feb 2022
Transactions value $: $0
Form type: 4
Filing time: 16 Feb 2022, 20:01:33 UTC
Previous filing: 05 Jan 2022
Next filing: 03 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FGEN	Common Stock	Award	$0	+60K	+61.14%	$0.00	158K	14 Feb 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FGEN	Stock Option (Right to Buy)	Award	$0	+100K		$0.00	100K	14 Feb 2022	Common Stock	100K	$15.60	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the grant of restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 6, 2023, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years.
F2	Twenty-five percent of the shares subject to the option will vest on March 1, 2023, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years.